NEW YORK (GenomeWeb News) — Great Basin said today that it has secured $9.5 million in Series B funding.

The Salt Lake City-based company will use the funding to expand manufacturing and fund research and development, including further developing and expanding the test menu for its Portrait Analyzer molecular diagnostics platform.

Great Basin said that it will also use the funds to expand global commercialization efforts.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.